In line with this, we measured strong expression changes of FXR downstream targets in hepatic (bsep, cyp7a1, shp) and ileal (shp, fgf15) tissue of NASH rats treated with cilofexor (Supplementary Figure S2). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.